CRF1-R Activation of the Dynorphin/Kappa Opioid System in the Mouse Basolateral Amygdala Mediates Anxiety-Like Behavior

被引:155
作者
Bruchas, Michael R. [1 ]
Land, Benjamin B. [1 ,2 ]
Lemos, Julia C. [1 ,2 ]
Chavkin, Charles [1 ,2 ]
机构
[1] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
[2] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
CORTICOTROPIN-RELEASING-FACTOR; STRESS-INDUCED RELAPSE; ELEVATED PLUS-MAZE; COCAINE SEEKING; HIGH-AFFINITY; ANTAGONIST; INCREASES; DOPAMINE; CORTICOSTERONE; STIMULATION;
D O I
10.1371/journal.pone.0008528
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Stress is a complex human experience and having both rewarding and aversive motivational properties. The adverse effects of stress are well documented, yet many of underlying mechanisms remain unclear and controversial. Here we report that the anxiogenic properties of stress are encoded by the endogenous opioid peptide dynorphin acting in the basolateral amygdala. Using pharmacological and genetic approaches, we found that the anxiogenic-like effects of Corticotropin Releasing Factor (CRF) were triggered by CRF1-R activation of the dynorphin/kappa opioid receptor (KOR) system. Central CRF administration significantly reduced the percent open-arm time in the elevated plus maze (EPM). The reduction in open-arm time was blocked by pretreatment with the KOR antagonist norbinaltorphimine (norBNI), and was not evident in mice lacking the endogenous KOR ligand dynorphin. The CRF1-R agonist stressin 1 also significantly reduced open-arm time in the EPM, and this decrease was blocked by norBNI. In contrast, the selective CRF2-R agonist urocortin III did not affect open arm time, and mice lacking CRF2-R still showed an increase in anxiety-like behavior in response to CRF injection. However, CRF2-R knockout animals did not develop CRF conditioned place aversion, suggesting that CRF1-R activation may mediate anxiety and CRF2-R may encode aversion. Using a phosphoselective antibody (KORp) to identify sites of dynorphin action, we found that CRF increased KORp-immunoreactivity in the basolateral amygdala (BLA) of wildtype, but not in mice pretreated with the selective CRF1-R antagonist, antalarmin. Consistent with the concept that acute stress or CRF injection-induced anxiety was mediated by dynorphin release in the BLA, local injection of norBNI blocked the stress or CRF-induced increase in anxiety-like behavior; whereas norBNI injection in a nearby thalamic nucleus did not. The intersection of stress-induced CRF and the dynorphin/KOR system in the BLA was surprising, and these results suggest that CRF and dynorphin/KOR systems may coordinate stress-induced anxiety behaviors and aversive behaviors via different mechanisms.
引用
收藏
页数:9
相关论文
共 53 条
[1]
Sensitivity to stress: Dysregulation of CRF pathways and disease development [J].
Bale, TL .
HORMONES AND BEHAVIOR, 2005, 48 (01) :1-10
[2]
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress [J].
Bale, TL ;
Contarino, AB ;
Smith, GW ;
Chan, R ;
Gold, LH ;
Sawchenko, PE ;
Koob, GF ;
Vale, WW ;
Lee, KF .
NATURE GENETICS, 2000, 24 (04) :410-414
[3]
BALE TL, 2001, ANN REV PHARM TOXICO, V11, P523
[4]
Control of hormonal stress reactivity by the endogenous opioid system [J].
Bilkei-Gorzo, Andras ;
Racz, Ildiko ;
Michel, Kerstin ;
Mauer, Daniela ;
Zimmer, Anne ;
Klingmueller, Dietrich ;
Zimmer, Andreas .
PSYCHONEUROENDOCRINOLOGY, 2008, 33 (04) :425-436
[5]
Stress-induced p38 mitogen-activated protein kinase activation mediates κ-opioid-dependent dysphoria [J].
Bruchas, Michael R. ;
Land, Benjamin B. ;
Aita, Megumi ;
Xu, Mei ;
Barot, Sabiha K. ;
Li, Shuang ;
Chavkin, Charles .
JOURNAL OF NEUROSCIENCE, 2007, 27 (43) :11614-11623
[6]
Bruchas MR., 2009, BRAIN RES
[7]
BRUELAS MR, 2007, J BIOL CHEM, V282, P29803
[8]
CORTICOTROPIN-RELEASING FACTOR INDUCES A PLACE AVERSION INDEPENDENT OF ITS NEUROENDOCRINE ROLE [J].
CADOR, M ;
AHMED, SH ;
KOOB, GF ;
LEMOAL, M ;
STINUS, L .
BRAIN RESEARCH, 1992, 597 (02) :304-309
[9]
Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn [J].
Carey, A. N. ;
Borozny, K. ;
Aldrich, J. V. ;
McLaughlin, J. P. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 569 (1-2) :84-89
[10]
Depressive-like effects of the κ-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats [J].
Carlezon, WA ;
Béguin, C ;
DiNieri, JA ;
Baumann, MH ;
Richards, MR ;
Todtenkopf, MS ;
Rothman, RB ;
Ma, ZZ ;
Lee, DYW ;
Cohen, BM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01) :440-447